Expression and function of angiopoietin-1 in breast cancer

British Journal of Cancer

Volumn 83, Issue 9, 2000, Pages 1154-1160

  Hayes, A J ^a   Huang, W Q ^a   Yu, J ^a   Maisonpierre, P C ^b   Liu, A ^a   Kern, F G ^c   Lippman, M E ^a   McLeskey, S W ^a   Li, L Y ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; Angiopoietin; Breast cancer; Gene expression; Neovascularization; Tumorigenesis

Indexed keywords

ANGIOPOIETIN 1; FIBROBLAST GROWTH FACTOR 1; RNA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION;

EID: 0033753903     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1437     Document Type: Article

References (32)

1. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
2. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
3. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
4. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
5. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors
6. Vasculayization of the mouse embryo: A study of flk-1, tek, tie, and vascular endothelial growth factor expression during development
7. Laser capture microdissection
8. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
9. Tumor angiogenesis: Therapeutic implications
10. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
11. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells
12. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
13. Angiopoietin-1 induces sprouting angiogenesis in vitro
14. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ
15. Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells
16. Distinct rat genes with ralated profiles of expression define a TIE receptor tyrosine kinase family
17. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
18. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice
19. Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor
20. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
21. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
22. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
23. Failure of blood-island formation and vasculogenesis in Flk1-deficient mice
24. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
25. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
26. Increased vascularization in mice overexpressing angiopoietin-1
27. SR alpha promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the RU5 segment of human T-cell leukemia virus type 1 long terminal repeat
28. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
29. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
30. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
31. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis
32. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice